Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 2, 2007, Pages 342-350

  An, Yong ^a   Xiao, Ying Bin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; HUMAN GROWTH HORMONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PREALBUMIN; SERUM AMYLOID A; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOPULMONARY BYPASS; CELL PROLIFERATION; CONTROLLED STUDY; HORMONE ACTION; IMMUNE RESPONSE; INFLAMMATION; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; TREATMENT OUTCOME;

ACUTE DISEASE; ACUTE-PHASE REACTION; ANIMALS; CARDIOPULMONARY BYPASS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMAN GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER DISEASES; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 34447643738     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.02.036     Document Type: Article

References (30)

1. Franke A., Lante W., Fackeldey V., Becker H.P., Kurig E., Zoller L.G., et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know?. Eur J Cardiothorac Surg. 28 (2005) 569-575
2. Michalopoulos A., Alivizatos P., and Geroulanos S. Hepatic dysfunction following cardiac surgery: determinants and consequences. Hepatogastroenterology 5 (1997) 779-783
3. An Y., Xiao Y.B., and Zhong Q.J. Hyperbilirubinemia after extracorporeal circulation surgery: A recent and prospective study. World J Gastroenterol. 12 (2006) 6722-6726
4. Cagli K., Ulas M.M., Ozisik K., Kale A., Bakuy V., Emir M., et al. The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion. 20 (2005) 45-51
5. Morariu A.M., Loef B.G., Aarts L.P., Rietman G.W., Rakhorst G., van Oeveren W., et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 128 (2005) 2677-2687
6. Ueyama K., Nishimura K., Nishina T., Nakamura T., Ikeda T., and Komeda M. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery. ASAIO J. 50 (2004) 369-372
7. van den Goor J., Nieuwland R., van den Brink A., van Oeveren W., Rutten P., Tijssen J., et al. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response. Eur J Cardiothorac Surg. 26 (2004) 926-931
8. Varan B., Tokel K., Mercan S., Donmez A., and Aslamaci S. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose. Pediatr Cardiol. 23 (2002) 437-441
9. Brix-Christensen V., Tonnesen E., Sorensen I.J., Bilfinger T.V., Sanchez R.G., and Stefano G.B. Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute-phase protein responses in patients undergoing cardiac surgery. Acta Anaesthesiol Scand. 42 (1998) 63-70
10. Wu X., Herndon D.N., and Wolf S.E. Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3. Shock 19 (2003) 314-320
11. Johnson T.S., O'Leary M., Justice S.K., Maamra M., Zarkesh-Esfahani S.H., Furlanetto R., et al. Differential expression of suppressors of cytokine signalling genes in response to nutrition and growth hormone in the septic rat. J Endocrinol. 169 (2001) 409-415
12. Chrysopoulo M.T., Jeschke M.G., Ramirez R.J., Barrow R.E., and Herndon D.N. Growth hormone attenuates tumor necrosis factor alpha in burned children. Arch Surg. 134 (1999) 283-286
13. Xu B.C., Wang X., Darus C.J., and Kopchick J.J. Growth hormone Promotes the association of transcription factor STAT5 with the growth hormone receptor. J Biol Chem. 271 (1996) 19768-19773
14. Jeschke M.G., Barrow R.E., and Herndon D.N. Recombinant human growth hormone treatment in pediatric burn patients and its role during the hepatic acute phase response. Crit Care Med. 28 (2000) 1578-1584
15. Jeschke M.G., Herndon D.N., Wolf S.E., DebRoy M.A., Rai J., Lichtenbelt B.J., et al. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res. 83 (1999) 122-129
16. Yumet G., Shumate M.L., Bryant D.P., Lang C.H., and Cooney R.N. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling. Crit Care Med. 34 (2006) 1420-1427
17. Moshage H. Cytokines and the hepatic acute phase response. J Pathol. 181 (1997) 257-266
18. Livingston D.H., Mosenthal A.C., and Deitch E.A. Sepsis and multiple organ dysfunction syndromes: a clinical-mechanistic overview. New Horizons 3 (1995) 257-266
19. De Maio A., de Mooney M.L., Matesic L.E., Paidas C.N., and Reeves R.H. Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 10 (1998) 319-323
20. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappaB. Ann Rev Cell Biol. 10 (1994) 405-455
21. Nolten L.A., Steenbergh P.H., and Sussenbach J.S. Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor 1 gene via two distinct binding sites. Mol Endocrinol. 9 (1995) 1488-1499
22. Balteskard L., Unneberg K., Mjaaland M., Jenssen T.G., and Revhaug A. Growth hormone and insulin-like growth factor 1 promote intestinal uptake and hepatic release of glutamine in sepsis. Ann Surg. 228 (1998) 131-138
23. Selzman C.H., Shames B.D., Miller S.A., Pulido E.J., Meng X., Mcintyre R.C., et al. Therapeutic implications of interleukin-10 in surgical disease. Shock 10 (1998) 3089-3094
24. Gilpin D.A., Hsieh C.C., Kuninger D.T., Herndon D.N., and Papaconstantinou J. Effect of the thermal injury on the expression of transcription factors that regulate acute phase response genes: The response of C/EBP-α, C/EBP-β, and C/EBP-δ to thermal injury. Surgery 119 (1996) 674-682
25. Jarrar D., Herndon D.N., Wolf S.E., and Papaconstantinou J. Growth hormone treatment after burn affects expression of C/EBPs, regulators of the acute phase response. [abstract]. J Burn Care Rehab. 19 suppl (1998) S163
26. Nolten L.A., Steenbergh P.H., and Sussenbach J.S. Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor 1 gene via two distinct binding sites. Mol Endocrinol. 9 (1995) 1488-1499
27. Lazarus D.D., Moldawer L.L., and Lowry S.F. Insulin-like growth factor 1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6. Lymphokine Cytokine Res. 12 (1993) 219-223
28. Steller H. Mechanisms and genes of cellular suicide. Science 267 (1995) 1445-1449
29. Lightfoot Jr. E., Horton J.W., Maass D.L., White D.J., McFarland R.D., and Lipsky P.E. Major burn trauma in rats promotes cardiac and gastrointestinal apoptosis. Shock 11 (1999) 29-34
30. Bradham C.A., Plumpe J., Manns M.P., Brenner D.A., and Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol. 275 (1998) G387-G392